{
    "Trade/Device Name(s)": [
        "Dimension\u00ae LOCI\u00ae Thyroid Stimulating Hormone Flex\u00ae reagent cartridge (TSHL)",
        "Dimension\u00ae LOCI\u00ae Free Thyroxine Flex\u00ae reagent cartridge (FT4L)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K243570",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081074",
        "K073604"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW",
        "CEC"
    ],
    "Summary Letter Date": "March 13, 2025",
    "Summary Letter Received Date": "March 14, 2025",
    "Submission Date": "March 13, 2025",
    "Regulation Number(s)": [
        "21 CFR 862.1690",
        "21 CFR 862.1695"
    ],
    "Regulation Name(s)": [
        "Thyroid Stimulating Hormone Test System",
        "Free Thyroxine Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Thyroid Stimulating Hormone (TSH)",
        "Free Thyroxine (FT4)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae EXL\u2122 integrated chemistry system with LOCI\u00ae Module"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous sandwich chemiluminescent immunoassay",
        "Homogeneous sequential chemiluminescent immunoassay",
        "LOCI\u00ae technology"
    ],
    "Methodologies": [
        "Chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension LOCI Thyroid Stimulating Hormone and Free Thyroxine Flex reagent cartridges using chemiluminescent immunoassay for thyroid disease diagnosis on Dimension EXL systems",
    "Indications for Use Summary": "Quantitative measurement of thyroid stimulating hormone (TSH) and free thyroxine (FT4) in human serum and plasma to aid in the diagnosis and monitoring of thyroid disease using the Dimension EXL integrated chemistry system with LOCI Module",
    "fda_folder": "Clinical Chemistry"
}